Letter: Zinc in acrodermatis enteropathica

Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disorders.

Journal of public health (Oxford, England)·2022

Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects.

Clinical epigenetics·2021

Long-term trends in antithrombotic drug prescriptions among adults aged 80 years and over from primary care: a temporal trends analysis using electronic health records.

Annals of epidemiology·2018

Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.

Diabetes, obesity & metabolism·2013

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

Alimentary pharmacology & therapeutics·2013

Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.

Alimentary pharmacology & therapeutics·2012

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Gut microbiota dysbiosis in autism spectrum disorder: 10 years of progress on compositional alterations, metabolic/immune mechanisms, and therapeutic strategies.

Frontiers in neuroscience·2026

A bedside-to-outside model of human nutrition research.

Cell metabolism·2026

Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome.

Frontiers in nutrition·2026

Gut microbiota dysbiosis in sepsis and sepsis-associated organ injury: mechanisms, gut-organ axes, and therapeutic strategies.

Frontiers in microbiology·2026

Differential Associations of Iron Deficiency with Renal Progression and Mortality in Anemic Non-Dialysis-Dependent Chronic Kidney Disease.

Kidney diseases (Basel, Switzerland)·2026

Sleep and obesity-known interactions and open questions.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026

Related Experiment Videos

Letter: Zinc in acrodermatis enteropathica

Related Concept Videos

Developing and testing a case-management intervention to support the return to work of health care workers with common mental health disorders.

Novel DNA methylation signatures of tobacco smoking with trans-ethnic effects.

Long-term trends in antithrombotic drug prescriptions among adults aged 80 years and over from primary care: a temporal trends analysis using electronic health records.

Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Gut microbiota dysbiosis in autism spectrum disorder: 10 years of progress on compositional alterations, metabolic/immune mechanisms, and therapeutic strategies.

A bedside-to-outside model of human nutrition research.

Serum zinc deficiency and progression of cardiovascular- kidney-metabolic syndrome.

Gut microbiota dysbiosis in sepsis and sepsis-associated organ injury: mechanisms, gut-organ axes, and therapeutic strategies.

Differential Associations of Iron Deficiency with Renal Progression and Mortality in Anemic Non-Dialysis-Dependent Chronic Kidney Disease.

Sleep and obesity-known interactions and open questions.

Related Experiment Videos

Letter: Zinc in acrodermatis enteropathica

Related Concept Videos

Related Articles